Pharmaceutical News

RSS

GSK to supply antiretroviral drugs to Russia at discounted price

GlaxoSmithKline has announced it would supply 90,000 packs of its antiretroviral drugs Combivir, Epivir and Ziagen to Russia at discounted prices by the end of 2006, the AFP/Yahoo! U.K and Ireland reports (AFP/Yahoo! U.K and Ireland, 9/15).

18 Sep 2006

More physicians now visit web sites to find information on brand-name prescription drugs

An increased number of physicians visited Web sites that promote brand-name prescription drugs during the first six months of 2006 to seek information about dosages and side effects, according to a recent Manhattan Research study, the Newark Star-Ledger reports.

18 Sep 2006

Chile to distribute Plan B emergency contraceptive at no cost to girls over age 14

Chilean Health Minister Maria Soledad Barria earlier this month announced that the government will distribute Barr Laboratories' emergency contraceptive Plan B -- which can prevent pregnancy if taken up to 72 hours after sexual intercourse -- in public clinics to girls ages 14 and older at no cost and without parental consent, the Christian Science Monitor reports.

14 Sep 2006

Bristol-Myers Squibb and Medivira announce collaboration to commercialize HIV treatment

Bristol-Myers Squibb and Medivir AB have announced a worldwide collaboration to develop and commercialize MIV-170, a preclinical non-nucleoside reverse transcriptase inhibitor, or NNRTI, intended for the treatment of HIV-1 infection in adults as part of an antiretroviral drug regimen.

13 Sep 2006

Accutane iPledge program requirements leading to illegal online sales

The strict regulations governing the prescription and use of the acne drug isotretinoin, sold by Roche under the brand name Accutane, are affecting the drug's sale and dispensation and raising concerns about sales of the medication over the Internet, the Wall Street Journal reports (Corbett Dooren, Wall Street Journal, 9/12).

13 Sep 2006

Department of Justice joins Whistleblower lawsuit alleging overcharging by drug company Dey

The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.

13 Sep 2006

GlaxoSmithKline settles dispute with IRS

GlaxoSmithKline has announced that it has settled its transfer pricing tax dispute with the US Internal Revenue Service (IRS).

12 Sep 2006

TV advertising of prescription drugs may increase visits to doctor not actual sales

TV advertising of prescription drugs may be prompting more people to visit their doctors rather than substantially increasing sales of advertised drugs, according to research led by the Medical University of South Carolina (MUSC).

12 Sep 2006

Drug ads and their influence on patients and doctors

Television ads for prescription drugs are everywhere, enticing people to ask their doctors for this drug or that one, but the effect this type of ad has on American healthcare may be more complicated than simply inducing patients to choose one brand or the other, according to a team of researchers.

12 Sep 2006

FDA approves Watson's generic version of Barr's contraceptive pill Seasonale

FDA on Thursday approved Watson Pharmaceuticals' marketing application for its generic version of Barr Laboratories' extended-cycle oral contraceptive Seasonale, Reuters reports.

11 Sep 2006

Federal Judge refuses to dismiss lawsuit challenging Illinois rule requiring pharmacists to fill prescriptions for emergency contraception

U.S. District Judge Jeanne Scott on Wednesday ruled against a motion to dismiss a lawsuit that aims to block an Illinois rule that requires pharmacies to dispense prescriptions for emergency contraception -- which can prevent pregnancy if taken within 72 hours of sexual intercourse -- saying the plaintiffs have a legitimate claim that the rule infringes on their religious rights.

11 Sep 2006

Johns Hopkins ACG team releases pharmacy-based predictive model

Researchers at the Johns Hopkins Bloomberg School of Public Health have developed Johns Hopkins ACG Rx-PM - new predictive modeling software based on retail pharmacy claims information.

11 Sep 2006

New drug sorts out premature ejaculation

According the American Urological Association, premature ejaculation affects about 20% of males in the U.S. aged 18-59.

11 Sep 2006

Surveys show most pharmacists, doctors believe Medicare Drug Benefit helps patients, though most think it is too complicated

Most pharmacists and physicians believe that the Medicare prescription drug benefit has helped beneficiaries save money on their medications but also believe that the program is overly complex, according to two surveys released on Thursday by the Kaiser Family Foundation, the San Francisco Chronicle reports.

11 Sep 2006

Sacramento City Council approves sale of nonprescription needles

The Sacramento, Calif., City Council on Tuesday voted 6-2 to approve a measure that will allow the nonprescription sale of syringes to adults, the Sacramento Bee reports (Stern, Sacramento Bee, 9/6).

7 Sep 2006

FDA asks U.S. Marshals to seize dietary supplements

At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00.

6 Sep 2006

Sen. Santorum, opponent Casey differ in opinion of FDA approval of nonprescription Plan B sales

Sen. Rick Santorum and Pennsylvania Treasurer Bob Casey on Sunday on NBC's "Meet the Press showed "sharp" disagreement over FDA's recent approval of nonprescription sales of Barr Laboratories' emergency contraceptive Plan B.

5 Sep 2006

Some find Accutane iPledge program requirements burdensome

Six months after the introduction of iPledge -- with which all people taking the acne drug isotretinoin, sold by Roche under the brand name Accutane, must register to receive their prescriptions - many patients and dermatologists "complain that the rules of iPledge are onerous and unworkable

5 Sep 2006

Some drug companies experiencing higher prescription volume, revenue with Medicare drug benefit

The Philadelphia Inquirer on Monday examined how the Medicare prescription drug benefit "is boosting prescription volume and revenue for drug companies."

5 Sep 2006

Licensing arrangement reached for antiepileptic drug developed at Hebrew University

A worldwide licensing arrangement for development, production and marketing of an antiepileptic drug created at the Hebrew University of Jerusalem has been signed by Shire Pharmaceuticals with Yissum, the Hebrew University's technology transfer company.

5 Sep 2006

Pharmaceutical News

GSK to supply antiretroviral drugs to Russia at discounted price

More physicians now visit web sites to find information on brand-name prescription drugs

Chile to distribute Plan B emergency contraceptive at no cost to girls over age 14

Bristol-Myers Squibb and Medivira announce collaboration to commercialize HIV treatment

Accutane iPledge program requirements leading to illegal online sales

Department of Justice joins Whistleblower lawsuit alleging overcharging by drug company Dey

GlaxoSmithKline settles dispute with IRS

TV advertising of prescription drugs may increase visits to doctor not actual sales

Drug ads and their influence on patients and doctors

FDA approves Watson's generic version of Barr's contraceptive pill Seasonale

Federal Judge refuses to dismiss lawsuit challenging Illinois rule requiring pharmacists to fill prescriptions for emergency contraception

Johns Hopkins ACG team releases pharmacy-based predictive model

New drug sorts out premature ejaculation

Surveys show most pharmacists, doctors believe Medicare Drug Benefit helps patients, though most think it is too complicated

Sacramento City Council approves sale of nonprescription needles

FDA asks U.S. Marshals to seize dietary supplements

Sen. Santorum, opponent Casey differ in opinion of FDA approval of nonprescription Plan B sales

Some find Accutane iPledge program requirements burdensome

Some drug companies experiencing higher prescription volume, revenue with Medicare drug benefit

Licensing arrangement reached for antiepileptic drug developed at Hebrew University

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News